CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Open-market buy Director bought 12,500 shares at $7.98 ($99,750)
- 4 Open-market buy Director bought 3,173 shares at $7.88 ($25,003)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 11,625 shares at $10.06 ($116,995)
- 4 Shares withheld for taxes President and CEO gave up 8,059 shares (to pay taxes)
- 4 Exercise or conversion Executive Vice Chair acquired 11,111 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Planned sale Director sold 11,625 shares at $10.30 ($119,705)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,627 shares (to pay taxes)
- 4 Planned sale Director sold 11,625 shares at $12.65 ($147,045)
- 4 Open-market buy 10% owner bought 850,000 shares at an average $11.86 ($10,081,721)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 581,765 shares at an average $18.03 ($10,489,446)
- 4 Shares withheld for taxes Chief Medical Officer gave up 25,546 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift President and CEO gave 2,500 shares (gift)
- 4 Gift President and CEO gave 20,000 shares (gift)
- 4 Shares withheld for taxes Executive Vice Chair gave up 14,943 shares (to pay taxes)
Page 4 of 23 · 459 filings